Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Equity Ratio for 14 consecutive years, with 0.12 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 56.02% to 0.12 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.12, a 56.02% decrease, with the full-year FY2025 number at 0.15, down 34.92% from a year prior.
  • Equity Ratio was 0.12 for Q4 2025 at Aytu Biopharma, down from 0.19 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.52 in Q2 2021 to a low of 0.12 in Q4 2025.
  • A 5-year average of 0.29 and a median of 0.28 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: tumbled 67.89% in 2021, then grew 17.65% in 2025.
  • Aytu Biopharma's Equity Ratio stood at 0.47 in 2021, then crashed by 31.3% to 0.32 in 2022, then decreased by 22.73% to 0.25 in 2023, then grew by 5.75% to 0.26 in 2024, then crashed by 56.02% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Equity Ratio are 0.12 (Q4 2025), 0.19 (Q3 2025), and 0.15 (Q2 2025).